Studies on sustained release liquid oral formulation of Diltiazem hydrochloride: Reconstitutable suspension

Indian Drugs

Volumn 40, Issue 12, 2003, Pages 701-706

  Bhalerao, S S ^b   Rane, M S ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b PRIN K M KUNDNANI COLLEGE OF PHARMACY   (India)

Author keywords

Bitter taste masking; Diltiazem hydrochloride; Microspheres; Reconstitution; Suspension; Sustained release

Indexed keywords

CHLORIDE; DILTIAZEM; MICROSPHERE; SOLVENT;

AQUEOUS SOLUTION; ARTICLE; DRUG FORMULARY; DRUG STABILITY; DRUG SYNTHESIS; EVAPORATION; LOADING TEST; MASKING; MICROEMULSION; MICROENCAPSULATION; PALATABILITY; POLYMERIZATION; SUSPENDED PARTICULATE MATTER; SUSTAINED DRUG RELEASE; TASTE; TECHNIQUE;

EID: 11144281939     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sellassie I.G., 1994, Multiparticulate Oral Drug Delivery (New York: Marcel Dekker Inc.).
2. Howard C. A., 1981, Introduction of Pharmaceutical Dosage Forms (Lea and Febiger, Philadelphia, PA), pp. 139 - 166.
3. Smith H. A., Evanson R. V., and Sperandio G. J., 1960, The development of a liquid antihistaminic preparation with sustained release properties. J. of American Pharma. Asso., Sci. Edn., 49, 94 - 97.
4. Habib M. J., and Mesue R., 1995, Development of controlled release formulations of ketoprofen for oral use. Drug Development and Industrial Pharmacy, 21 12, 1463 - 1472.
5. Bodmeier R., Chen H., Tyle P., and Jarosz P., 1991, Pseudoephedrine HCl microspheres formulated into an oral suspension dosage form J. of Controlled Release, 15, 65 - 77.
6. Kawashima Y., Iwamoto T., Niwa H., Takeuchi H. and Itoh Y., 1991, Preparation and characterization of new controlled release ibuprofen suspension for improving suspendability. International J. of Pharmaceutics, 75, 25 - 36.
7. Dalal P.S., and M. M. Narurkar, 1991, In vitro and in vivo evaluation of sustained release suspensions of ibuprofen. International J. of Pharmaceutics, 73, 157 - 162.
8. Chaffman M., and Brogden R. N., 1985, Diltiazem, a review of its pharmacological properties and therapeutic efficacy. Drugs, 29, 387 - 454.
9. Maxxo D. J., Obetz C. L., and Shuster J., 1994, Diltiazem hydrochloride. In Analytical Profiles of Drug Substances and Excipients, Vol. 23, edited by H. Brittain (New York Academic Press. Inc.), pp. 53 - 98.
10. Bhalerao S. S., Lalla J. K. and Rane, M. S., Study of processing parameters influencing the properties of Diltiazem hydrochloride microspheres, J. Microencapsulation, 18 3 2001, 299-307.
11. Delgado A., Gallardo V., Salcedo J., and Gonzalez-Caballero F., 1990, Study of electrokinetic and stability properties of nitrofurantoin suspensions. Part I. Electrokinetics. J. of Pharmaceutical Sciences, 79, 82 - 86.
12. Impurities: residual solvent, VICH topic GL 18, CVMP/VICH/502/99-Final (http://www.eudra.org).
13. Bhalerao S. S., Lalla J. K. and Rane M. S., A study of electrokinetic and stability properties of suspensions of Diltiazem hydrochloride microspheres, Indian Drugs, 389 2001, 464 - 467.